Benchmarking Leverage Pharmaceutical Valuation 
CFO News Room
FEBRUARY 2, 2022
So, you have the headquarters of a big pharmaceutical company, and they — they’re looking to raise some cash, maybe not a pharmaceutical company, but some other business. CONROD: I — I think the — in this low interest rate environment people are looking for yield and income, and how do they — they have a — they have a benchmark.
Barry Ritholtz
MARCH 14, 2023
Everybody wants to sell a company when they get a good valuation. Obviously, profits, very important to company valuation — BERNSTEIN: Absolutely. The other thing we do, Barry, is we group valuation as a sentiment indicator. So we do a lot of valuation work. BERNSTEIN: Correct. RITHOLTZ: Right. RITHOLTZ: Oh, really?
Expert insights. Personalized for you.
100 
Let's personalize your content